ORAH MAHTOV: Open Payments
NPI 1184133944 · VAN NUYS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$368 in 12 payments from 7 companies in 2025. Trend: 2023 $420 · 2024 $558 · 2025 $368
Food & beverage: $368
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 1 | $125 |
| Virtus Pharmaceuticals LLC | 3 | $80 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $53 |
| Collegium Pharmaceutical, Inc. | 2 | $32 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $29 |
| Spinal Simplicity, LLC | 1 | $25 |
| Fidia Pharma USA Inc. | 1 | $23 |
Products named: CEREZYME, LEVORPHANOL TARTRATE, JOURNAVX, Belbuca, RELISTOR, HA MINUTEMAN G3-R, HYMOVIS.
Industry payments across CA — which companies pay providers there.
